• Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Pnpla3/Adiponutrin deficiency in mice does not contribute to fatty liver disease or metabolic syndrome.

PNPLA3 (adiponutrin, calcium-independent phospholipase A(2) epsilon [iPLA(2)ε]) is an adipose-enriched, nutritionally regulated protein that belongs to the patatin-like phospholipase domain containing (PNPLA) family of lipid metabolizing proteins. Genetic variations in the human PNPLA3 gene (i.e., the rs738409 I148M allele) has been strongly and repeatedly associated with fatty liver disease. Although human PNPLA3 has triacylglycerol (TAG) hydrolase and transacylase activities in vitro, its in vivo function and physiological relevance remain controversial. The objective of this study was to determine the metabolic consequences of global targeted deletion of the Pnpla3 gene in mice. We found that Pnpla3 mRNA expression is altered in adipose tissue and liver in response to acute and chronic nutritional challenges. However, global targeted deletion of the Pnpla3 gene in mice did not affect TAG hydrolysis, nor did it influence energy/glucose/lipid homoeostasis or hepatic steatosis/injury. Experimental interventions designed to increase Pnpla3 expression (refeeding, high-sucrose diet, diet-induced obesity, and liver X receptor agonism) likewise failed to reveal differences in the above-mentioned metabolic phenotypes. Expression of the Pnpla3 paralog, Pnpla5, was increased in adipose tissue but not in liver of Pnpla3-deficient mice, but compensatory regulation of genes involved in TAG metabolism was not identified. Together these data argue against a role for Pnpla3 loss-of-function in fatty liver disease or metabolic syndrome in mice.

Pubmed ID: 21068004

Authors

  • Basantani MK
  • Sitnick MT
  • Cai L
  • Brenner DS
  • Gardner NP
  • Li JZ
  • Schoiswohl G
  • Yang K
  • Kumari M
  • Gross RW
  • Zechner R
  • Kershaw EE

Journal

Journal of lipid research

Publication Data

February 17, 2011

Associated Grants

  • Agency: Austrian Science Fund FWF, Id: F 3001-B19
  • Agency: Austrian Science Fund FWF, Id: F 3002-B19
  • Agency: NHLBI NIH HHS, Id: P01 HL-020948
  • Agency: NHLBI NIH HHS, Id: P01 HL-057278
  • Agency: NIDDK NIH HHS, Id: P30 DK057521
  • Agency: NIDDK NIH HHS, Id: P30-DK-036836
  • Agency: NHLBI NIH HHS, Id: RL1 HL-092550
  • Agency: Austrian Science Fund FWF, Id: Z 136-B05
  • Agency: Howard Hughes Medical Institute, Id:

Mesh Terms

  • Adipose Tissue
  • Animals
  • Energy Metabolism
  • Fatty Liver
  • Male
  • Metabolic Syndrome X
  • Mice
  • Mice, Knockout
  • Phospholipases A2, Calcium-Independent
  • Triglycerides